普雷斯蒂奇 PBH 深 沪
等待开盘 05-14 09:30:00 美东时间
51.81
+1.400
+2.78%
华盛通- 最 高52.05
- 今 开49.87
- 成交量 75.05万股
- 最 低 49.61
- 昨 收 50.41
- 总市值 245.16万
- 52周最高 87.12
- 市盈率 静 12.09
- 换手率 1586.11%
- 52周最低 49.28
- 委 比 -30.15%
- 总股本 4.73万
- 历史最高 90.04
- 量 比 1.05
- 振 幅 4.84%
- 历史最低 8.15
- 每 手 1
- 风险率 9.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | 普雷斯蒂奇 2026财年Q1营收2.82亿美元，同比下降5.0%；归母净利润0.54亿美元，同比增长7.6%
华盛资讯5月14日讯，普雷斯蒂奇公布2026财年Q1业绩，公司Q1营收2.82亿美元，同比下降5.0%，归母净利润0.54亿美元，同比增长7.6%。
今天 06:17
Prestige Consumer Sees FY2027 Adj EPS $4.42-$4.51 vs $4.79 Est; Sees Sales $1.100B-$1.121B vs $1.159B Est
Prestige Consumer (NYSE:PBH) is looking for FY2027 Adj EPS of $4.42-$4.51 vs $4.79 analyst estimate. sees sales of $1.100 billion-$1.121 billion vs $1.159 billion analyst estimate.
今天 04:32
Prestige Consumer Q4 Adj. EPS $1.23 Misses $1.39 Estimate, Sales $281.617M Miss $293.661M Estimate
Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.23 per share which missed the analyst consensus estimate of $1.39 by 11.51 percent. This is a 6.82 percent decrease over earnings of $1.32 per share from the
今天 04:31
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Oppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $65
Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lowers the price target from $77 to $65.
05-07 20:56
Prestige Bets $1 Billion On World's Most Iconic Nasal Strip
Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portfolio into sleep & breathing categories.
03-20 19:56
Prestige Consumer Health to acquire Breathe Right for $1.045B
Prestige Consumer Healthcare (PBH) to acquire the Breathe Right brand and other over-the-counter health products from Foundation Consumer Brands for $1.045 billion in cash under a definitive agreement...
03-20 18:33
Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips
Prestige Consumer Healthcare Inc. announced an agreement to acquire the Breathe Right® brand and other brands from Foundation Consumer Healthcare for $1.045 billion, net $900 million. Breathe Right, a leading nasal strip brand, expands Prestige’s portfolio into the sleep and better-breathing categories. The acquisition includes Dimetapp® and other established brands. Financial highlights: $200 million revenue, $95 million EBITDA, attractive mar...
03-20 10:15
Earnings Scheduled For March 19, 2026
Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to repo...
03-19 19:11
